McDermott, Christopher J.

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

Miller, T. M., Cudkowicz, M. E., Genge, A., Shaw, P. J., Sobue, G., Bucelli, R. C., Chiò, A., Van Damme, P., Ludolph, A. C., Glass, J. D., et al. (2022) · New England Journal of Medicine

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 966

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

Miller, T., Cudkowicz, M., Shaw, P. J., Andersen, P. M., Atassi, N., Bucelli, R. C., Genge, A., Glass, J., Ladha, S., Ludolph, A. L., et al. (2020) · New England Journal of Medicine

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 565

Diagnosis and management of motor neurone disease

McDermott, C. J., & Shaw, P. J. (2008) · BMJ

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 220

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)

Boddy, S. L., Giovannelli, I., Sassani, M., Cooper-Knock, J., Snyder, M. P., Segal, E., Elinav, E., Barker, L. A., Shaw, P. J., & McDermott, C. J. (2021) · BMC Medicine

Gut microbiota and healthAmyotrophic Lateral Sclerosis Research

Cited by 127

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis

Shepheard, S. R., Parker, M. D., Cooper-Knock, J., Verber, N. S., Tuddenham, L., Heath, P., Beauchamp, N., Place, E., Sollars, E. S. A., Turner, M. R., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry

Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders

Cited by 116

Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence

Harwood, C. A., McDermott, C. J., & Shaw, P. J. (2009) · Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 104

Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72

Ismail, A., Cooper-Knock, J., Highley, J. R., Milano, A., Kirby, J., Goodall, E., Lowe, J., Scott, I., Constantinescu, C. S., Walters, S. J., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry

Amyotrophic Lateral Sclerosis ResearchMultiple Sclerosis Research Studies

Cited by 65

Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK

Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., Kumar, P., Turton, E. J., White, D. A., Serfaty, M. A., et al. (2024) · The Lancet

Mindfulness and Compassion InterventionsAmyotrophic Lateral Sclerosis Research

Cited by 38

Needs and preferences for psychological interventions of people with motor neuron disease

Weeks, K. R., Gould, R. L., Mcdermott, C., Lynch, J., Goldstein, L. H., Graham, C. D., McCracken, L., Serfaty, M., Howard, R., Al-Chalabi, A., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Amyotrophic Lateral Sclerosis ResearchMindfulness and Compassion Interventions

Cited by 36

Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK

Musson, L. S., Collins, A., Opie-Martin, S., Bredin, A., Hobson, E. V., Barkhouse, E., Coulson, M. C., Stavroulakis, T., Gould, R. L., Al-Chalabi, A., et al. (2023) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

COVID-19 and healthcare impactsAmyotrophic Lateral Sclerosis Research

Cited by 17

A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.

Gould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., et al. (2022) · BMC Neurology

Mindfulness and Compassion InterventionsAmyotrophic Lateral Sclerosis Research

Cited by 16

Acceptance and Commitment Therapy for people living with motor neuron disease: an uncontrolled feasibility study

Gould, R. L., Rawlinson, C., Thompson, B., Weeks, K., Gossage-Worrall, R., Cantrill, H., Serfaty, M. A., Graham, C. D., McCracken, L. M., White, D., et al. (2023) · Pilot and Feasibility Studies

Mindfulness and Compassion InterventionsAmyotrophic Lateral Sclerosis Research

Cited by 10

Clinical aspects of motor neurone disease

Moore, C., McDermott, C. J., & Shaw, P. J. (2008) · Medicine

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 5

Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life

Keetharuth, A. D., Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C., Bradburn, M., Bursnall, M., Kumar, P., Turton, E. J., Tappenden, P., et al. (2024) · European Journal of Neurology

Health Systems, Economic Evaluations, Quality of LifeMindfulness and Compassion Interventions

Cited by 2